Sakamototide substrate peptide (TFA)

CAT:
804-HY-P1797A-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Sakamototide substrate peptide (TFA) - image 1

Sakamototide substrate peptide (TFA)

  • UNSPSC Description:

    Sakamototide substrate peptide TFA is a peptide substrate for members of the AMPK family of kinases, used in kinase activity assays[1][2].
  • Target Antigen:

    Others
  • Type:

    Peptides
  • Related Pathways:

    Others
  • Field of Research:

    Others
  • Assay Protocol:

    https://www.medchemexpress.com/sakamototide-substrate-peptide-tfa.html
  • Purity:

    98.79
  • Solubility:

    H2O : 100 mg/mL (ultrasonic)
  • Smiles:

    O=C(O)C(F)(F)F.O=C(N[C@@H](CC(C)C)C(N[C@@H](CC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H]([C@H](O)C)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N[C@@H](C)C(N[C@@H](CC(C)C)C(N[C@@H](CC1=CNC=N1)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C)N
  • Molecular Weight:

    1853.92
  • References & Citations:

    [1]Banerjee S,et al. Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinases. Biochem J. 2014 Jan 1;457(1):215-25.|[2]Banerjee S, et al. Interplay between Polo kinase, LKB1-activated NUAK1 kinase, PP1βMYPT1 phosphatasecomplex and the SCFβTrCP E3 ubiquitin ligase. Biochem J. 2014 Jul 15;461(2):233-45.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
  • Clinical Information:

    No Development Reported